KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- 06/19/2006 -- Pheromone Sciences Corp. (“Pheromone”) (TSX VENTURE: PHS) is pleased to announce that Dr. David White of the University of Western Ontario has agreed to become the principal researcher for the Company’s diabetes research project and has accepted an appointment as Chair of the Company’s Scientific Advisory board (“SAB”). Pheromone recently completed a $3.2 million private placement to fund this project, and it will be the Company’s primary research focus.